DEISY FRANCO: Open Payments
NPI 1912503996 · LOXAHATCHEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 64 payments from 15 companies in 2025. Trend: 2023 $1,020 · 2024 $1,567 · 2025 $1,579
Food & beverage: $1,579
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $404 |
| Novartis Pharmaceuticals Corporation | 8 | $179 |
| SANOFI-AVENTIS U.S. LLC | 3 | $163 |
| Novo Nordisk Inc | 8 | $152 |
| Amgen Inc. | 6 | $112 |
| Abbott Laboratories | 1 | $104 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $93 |
| Lilly USA, LLC | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $55 |
Products named: FARXIGA, LEQVIO, TZIELD, BREZTRI, OTEZLA, FREESTYLE LIBRE 3, Kerendia, Ozempic.
Industry payments across FL — which companies pay providers there.
